Literature DB >> 7878070

Effects of streptozotocin-induced diabetes and insulin treatment on blood pressure in the male rat.

M J Katovich1, K Hanley, G Strubbe, B E Wright.   

Abstract

Hyperinsulinemia may link diabetes to hypertension. We evaluated the effects of insulin on blood glucose and blood pressure in control and streptozotocin (STZ)-induced (60 mg/kg, i.v.) diabetes. Insulin was given daily for 10-14 weeks to both diabetic (0, 1, 2, and 3 U) and control (0, 2, and 3 U) male rats (n = 7-8/group). Indirect and direct blood pressures were measured as were blood glucose and several metabolic parameters. All treated rats became hyperinsulinemic. Untreated and 1 U insulin-treated diabetic rats were hyperglycemic. Higher doses of insulin significantly reduced blood glucoses in diabetic animals. Indirect blood pressure measurements were unchanged between groups. However, when measured directly, the untreated diabetic rats had significantly lower pressures that did untreated controls. Insulin treatment at dosages above 1 U normalized blood pressure in diabetic animals. These same doses of insulin also restored to normal all the metabolic parameters associated with diabetes. Insulin treatment did not affect any of the parameters evaluated in nondiabetic rats. Collectively, the results show that STZ-induced diabetes results in a decrease in blood pressure and that insulin treatment can restore blood pressure in diabetic rats. Although the results suggest that insulin may be involved in restoring blood pressure in animals with a carbohydrate imbalance, the precise mechanism for elevating blood pressure is not known with certainty.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7878070     DOI: 10.3181/00379727-208-43860

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  6 in total

1.  Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis.

Authors:  S Satheesan; J L Figarola; T Dabbs; S Rahbar; R Ermel
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

2.  Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism.

Authors:  Jennifer M Sasser; Jennifer C Sullivan; Janet L Hobbs; Tatsuo Yamamoto; David M Pollock; Pamela K Carmines; Jennifer S Pollock
Journal:  J Am Soc Nephrol       Date:  2006-12-13       Impact factor: 10.121

3.  Inner retinal oxygen delivery and metabolism in streptozotocin diabetic rats.

Authors:  Justin Wanek; Pang-Yu Teng; Norman P Blair; Mahnaz Shahidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-13       Impact factor: 4.799

4.  Reduced GABAergic inhibition of kidney-related PVN neurons in streptozotocin-treated type 1 diabetic mouse.

Authors:  Yanyan Jiang; Hong Gao; Amanda M Krantz; Andrei V Derbenev; Andrea Zsombok
Journal:  J Neurophysiol       Date:  2013-08-21       Impact factor: 2.714

5.  Anti-inflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy.

Authors:  He-Ling Wen; Zhong-Shu Liang; Rui Zhang; Kan Yang
Journal:  Cardiovasc Diabetol       Date:  2013-03-25       Impact factor: 9.951

6.  Garlic Attenuates Plasma and Kidney ACE-1 and AngII Modulations in Early Streptozotocin-Induced Diabetic Rats: Renal Clearance and Blood Pressure Implications.

Authors:  Khaled K Al-Qattan; Martha Thomson; Divya Jayasree; Muslim Ali
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-18       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.